Valink Therapeutics
- Biotech or pharma, therapeutic R&D
Valink Therapeutics focusses on synergistic target/payload combinations to improve drug delivery in bispecific antibody-drug conjugates (bsADCs). We are progressing synergy-enabled bispecific ADC with improved payload delivery, identified from rapid screening of 300+ unique target combinations.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}